Cargando…
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Multiple myeloma (MM) is related to immune disorders, recent studys have revealed that immunotherapy can greatly benefit MM patients. Immune checkpoints can negatively modulate the immune system and are closely associated with immune escape. Immune checkpoint-related therapy has attracted much atten...
Autores principales: | Liu, Zhaoyun, Xu, Xintong, Liu, Hui, Zhao, Xianghong, Yang, Chun, Fu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685608/ https://www.ncbi.nlm.nih.gov/pubmed/38017516 http://dx.doi.org/10.1186/s40164-023-00456-5 |
Ejemplares similares
-
Therapeutic strategies to enhance immune response induced by multiple myeloma cells
por: Liu, Zhaoyun, et al.
Publicado: (2023) -
Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy
por: Liu, Zhaoyun, et al.
Publicado: (2022) -
PB2136: THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA
por: Liu, Zhaoyun, et al.
Publicado: (2023) -
Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients
por: Zhaoyun, Liu, et al.
Publicado: (2021) -
Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells
por: Liu, Zhaoyun, et al.
Publicado: (2023)